37 studies found for:    " February 05, 2012":" March 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
22 Completed Phase I/IIa Dose-escalation Clinical Study of VAC-3S
Condition: HIV-1 Infection
Interventions: Biological: VAC-3S;   Biological: Placebo
23 Completed Early Access to TMC114/r and Other AVT for Treatment-naive or Early Treatment Experienced in HIV-1 Patients
Condition: HIV-1
Intervention: Drug: TMC114/ritonavir
24 Unknown  Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
Conditions: To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT;   To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
Interventions: Radiation: Radiation therapy;   Other: Venepuncture
25 Active, not recruiting Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy
Condition: Tuberculosis
Intervention:
26 Completed Methadone Maintenance and HIV Prevention: A Window of Opportunity in China
Conditions: Capacity Building;   Drug Use;   HIV/AIDS
Intervention: Behavioral: MMT CARE
27 Recruiting Testing and Linkage to Care for Injecting Drug Users in Kenya
Condition: HIV Infection
Intervention: Behavioral: Point of Care CD4 count and peer case management
28 Completed An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulation (VF) of tenofovir 1% gel;   Drug: Reduced glycerin vaginal formulation (RGVF) of tenofovir 1% gel;   Radiation: Radiolabeling of study drugs and semen
29 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA009-00-VP;   Biological: Placebo vaccine
30 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Intervention: Biological: VRC-HIVADV014-00-VP Vaccine
31 Unknown  A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy
Conditions: Diabetic Neuropathy;   Chemotherapy Induced Neuropathy;   HIV Neuropathy;   Trauma Induced Neuropathy
Intervention: Drug: Neuron012703 (Medical Food)
32 Completed A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulations (original VF and reduced vaginal glycerin formulation RGVF) of tenofovir 1% gel;   Drug: Universal HEC Placebo Gel Formulation
33 Recruiting Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated
Condition: HIV-1
Interventions: Drug: EFV/FTC/TDF + Losartan;   Drug: EFV/FTC/TDF;   Drug: FTC/TDF + MK-0518;   Drug: FTC/TDF+MK-0518+Losartan
34 Completed
Has Results
Sevelamer for Reducing Endotoxemia and Immune Activation
Condition: HIV-1 Infection
Interventions: Drug: Sevelamer carbonate;   Device: Sevelamer carbonate
35 Completed
Has Results
Intervention to Retain HIV-positive Patients in Medical Care
Condition: Primary Care Appointment Keeping
Interventions: Behavioral: Enhanced contact plus behavioral skills;   Behavioral: Enhanced contact only;   Behavioral: Standard of Care
36 Active, not recruiting Project N-Liten- HIV Prevention for African American Women
Condition: Sexually Transmitted Diseases
Interventions: Behavioral: Horizons+General Health Promotion (GHP);   Behavioral: Horizons+Motivational Enhancement Therapy (GMET)
37 Active, not recruiting Operational Research for Cryptococcal Antigen Screening
Conditions: Cryptococcal Meningitis;   Cryptococcus Neoformans;   Cryptococcosis
Intervention: Drug: Fluconazole

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years